What researchers study
IGF-1 LR3 is a modified, longer-acting analogue of insulin-like growth factor 1 used in laboratory research on cell growth, protein synthesis, muscle biology and growth-factor signaling.
Research-use context: “What it is used for” below means what scientists and clinical researchers have investigated—not an instruction or recommendation for personal use.
Potential side effects & unknowns
The safety profile of IGF-1 LR3 itself has not been established for human use. As a class reference—not an LR3-specific safety claim—FDA-approved recombinant IGF-1 can cause hypoglycemia, hypersensitivity, intracranial hypertension and tissue hypertrophy, and carries warnings related to abnormal tissue growth.
Research highlight
IGF-1 signaling is well established as a regulator of growth and cellular metabolism, but those biological effects do not establish a safe or effective role for IGF-1 LR3 in healthy people. Robust controlled human LR3 outcome trials are lacking.
Video note: I did not find a clearly product-specific Dr. Jones, DC video for IGF-1 LR3 that I could verify, so no video is embedded here rather than attaching a loosely related one.
Research references
FDA: recombinant IGF-1 safety label ↗Looking for IGF-1 LR3?
Follow the tracked WILGO product link to see current inventory, exact product specifications and checkout pricing.